Regina Lewis, DO
Family Medicine · Tulsa, OKNPI 1942218789
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $4,750 of the $6,219 with a category attached, or 76.4%. 26 manufacturers reported payments, led by Organon at 44.7% of the total. Reporting peaked in 2021 at $3,001 and has fallen 86.9% since, to $393 in 2025.
Across 69 payments — averaging $90.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organon$3K
- Merck$2K
- Novo Nordisk$300
- Lilly USA, LLC$246
- Amarin Pharma, Inc.$111
- Boehringer Ingelheim$77
- plus $679 from 20 others
What the payments were for
- Speaking & faculty fees$4,75076%
- Food & beverage$1,46924%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organon | 4 | $2,779 |
| Merck | 5 | $2,028 |
| Novo Nordisk | 6 | $300 |
| Lilly USA, LLC | 8 | $246 |
| Amarin Pharma, Inc. | 7 | $111 |
| Boehringer Ingelheim | 4 | $77 |
| Exact Sciences | 3 | $65 |
| AbbVie | 3 | $63 |
| Biohaven Pharmaceuticals, Inc. | 2 | $58 |
| Harmony Biosciences LLC | 2 | $54 |
| Hologic Sales And Service, LLC | 3 | $53 |
| Pfizer | 3 | $47 |
| GSK | 3 | $43 |
| Bayer | 2 | $38 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $37 |
| Amgen | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
| Viiv Healthcare Company | 1 | $22 |
| Sanofi-aventis U.S. LLC | 1 | $22 |
| Inspire Medical Systems, Inc. | 1 | $20 |
| Dexcom, Inc. | 1 | $17 |
| Gilead | 1 | $16 |
| Novartis | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
| Therapeuticsmd, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,219 in reported general payments places this provider in the 85th percentile of 1,730 family medicine providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 24 | $471 |
| Omeprazole | 12 | $325 |
| Atorvastatin Calcium | 23 | $214 |
| Fluticasone Propionate | 12 | $212 |
| Cyclobenzaprine Hcl | 11 | $193 |
| Rosuvastatin Calcium | 12 | $179 |
| Amlodipine Besylate | 25 | $127 |
| Gabapentin | 14 | $121 |
| Levothyroxine Sodium | 27 | $119 |
| Montelukast Sodium | 14 | $92 |
| Lisinopril | 14 | $61 |
| Hydrochlorothiazide | 12 | $37 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Tulsa
- Geoffrey PlumleeTulsa$297K
- Kimberly HuttonTulsa$76K
- Sarah HallTulsa$52K
- Candy TingTulsa$28K
- Scott GhereTulsa$27K
- Michael MaddoxTulsa$24K
- Randall HerbelTulsa$23K
- Chandan LadTulsa$22K
- Scott SexterTulsa$21K
- Scott KochTulsa$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.